Cellectar Biosciences (NASDAQ:CLRB)

Cellectar Biosciences (NASDAQ:CLRB)

Share Price
$ 2.15
0 (0.00 %)
Market Cap
$20.20 m
Proactive Investors - Run By Investors For Investors

Cellectar Biosciences

Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Cellectar’s PDC platform is based on the company’s proprietary phospholipid ether analogs. These novel small-molecules have demonstrated highly selective uptake and retention in a broad range of...

52-week High/Low: $7.94 / $1.22
Market Cap: $20.20 m
col 3
col 4
col 5
col 6

Cellectar Biosciences Timeline

Cellectar Biosciences shares advance by 20% - extending in small measure on the 400% leap seen on Friday after its phospholipid ether analogs as cancer-targeting drug vehicles received their US Patent and Trademarks
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use